複方樟腦軟膏市場-應用（止痛、止癢、真菌感染）、配銷通路（零售、醫院、網上藥店）-全球預測（2024年-2032年）

Compound Camphor Ointment Market - Application (Pain Relief, Anti-itching, Fungal Infection), Distribution Channel (Retail, Hospital, Online Pharmacies) - Global Forecast (2024 - 2032)

出版日期: 2024年05月03日 | 出版商:

Global Market Insights Inc. | 英文 80 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於其治療特性，複方樟腦軟膏在治療各種病症的使用量不斷增加，預計從 2024 年到 2032 年，複方樟腦軟膏的市場規模將創下 4% 的複合年成長率。關節炎、肌肉疼痛和呼吸系統疾病等疾病的盛行率不斷上升，刺激了對有效局部治療的需求。據報道，到2050年，預計將有近10億人受到骨關節炎的影響。最近，人們對非處方藥（OTC）和天然產品的日益青睞進一步推動了產品的使用。

將樟腦軟膏納入其產品線的個人護理和製藥行業的擴張也將有利於市場成長。認知的提高也導致樟腦產品在各種治療和化妝品應用中得到更多採用，包括護膚和止癢配方。

複方樟腦軟膏產業分為應用領域、配銷通路和地區。

根據應用情況，真菌感染領域的市場價值將在2024年至2032年間錄得可觀的成長率。抑制真菌生長並緩解瘙癢、發紅和發炎症狀的能力也增強了其作為治療腳氣和癬等感染的局部藥物的吸引力。

從配銷通路來看，醫院藥房領域的複方樟腦軟膏產業預計將在2024-2032年出現顯著成長。這是因為這些設施在為各種病症提供專業和有效的治療方面發揮關鍵作用。醫院也利用樟腦軟膏的抗發炎、鎮痛和抗菌特性來管理患者護理，包括治療肌肉骨骼疼痛和皮膚病。

到2032年，亞太地區複方樟腦軟膏市場規模將大幅成長。軟膏的需求。真菌感染和濕疹等皮膚病以及關節炎等慢性病的流行也將增加該地區的產品需求。

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 8 章：公司簡介

Amrutanjan Health Care Limited
Caribe Natural LLC
Delon Laboratories Inc.
DLC Laboratories Inc.
Emu Joy
Focus Consumer Healthcare LLC
Greenbrier International, Inc.
McKesson Canada
Thera Wise
World Perfumes Inc.

簡介目錄

Product Code: 9347

Compound camphor ointment market size is set to record a 4% CAGR from 2024 to 2032 driven by increasing usage in treating a variety of conditions due to its therapeutic properties. The rising prevalence of conditions, such as arthritis, muscle pain, and respiratory ailments is fueling the demand for effective topical treatments. As per reports, by 2050, it is estimated that nearly 1 billion people will be affected by osteoarthritis. Of late, the growing preference for over-the-counter (OTC) remedies and natural products is further driving the product uptake.

The expansion of the personal care and pharmaceutical industries, which incorporate camphor ointments into their product lines will also favor the market growth. Increased awareness is also leading to the higher adoption of camphor-based products in various therapeutic and cosmetic applications, including skincare and anti-itch formulations.

The compound camphor ointment industry is divided into application, distribution channel and region.

Based on application, the market value from the fungal infection segment will record a decent growth rate between 2024 and 2032. This is due to anti-fungal properties, which make compound camphor an effective solution for various fungal skin conditions. The ability to inhibit fungal growth and provide symptomatic relief from itching, redness, and inflammation is also enhancing its appeal as a topical remedy for infections, such as athlete's foot and ringworm.

Based on distribution channel, the compound camphor ointment industry from the hospital pharmacies segment is anticipated to witness significant growth over 2024-2032. This is owing to the critical role these facilities play in providing specialized and effective treatments for a variety of conditions. Hospitals also use camphor ointments for their anti-inflammatory, analgesic, and antimicrobial properties in managing patient care, including the treatment of musculoskeletal pain and skin conditions.

Asia Pacific compound camphor ointment market size will record substantial growth through 2032. The rising popularity of herbal and natural remedies, combined with the growing middle-class population is necessitating accessible and effective health solutions in APAC, further fueling the demand for camphor ointments. The prevalence of skin disorders, such as fungal infections and eczema, along with chronic conditions like arthritis, will also add to the regional product demand.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360-degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing demand for natural remedies
  - 3.2.1.2 Rising prevalence of musculoskeletal disorders
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Associated safety concerns and side effects
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pipeline analysis
3.6 Reimbursement scenario
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Pain relief
5.3 Anti-itching
5.4 Fungal infection
5.5 Other applications

Chapter 6 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Retail pharmacies
6.3 Hospital pharmacies
6.4 Online pharmacies

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
- 7.3.7 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa